Sex‐Related Differences in Risk Factors Associated With Nonhealing or Recurrence of Hyperthyroidism in Patients With Graves' Disease Treated With Radioactive Iodine

ABSTRACT Background To evaluate sex‐related differences in the risk factors associated with nonhealing or recurrence of hyperthyroidism (NHRH) in patients with Graves' disease (GD) treated with radioactive iodine. Methods In total, 285 patients were enrolled. Data on radioactive iodine (RAI) do...

Full description

Saved in:
Bibliographic Details
Main Authors: Haolin Shen, Yuegui Wang, Jianmei Liao, Xianbo Zuo, Bo Zhang, Xiao Yang
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Health Care Science
Online Access:https://doi.org/10.1002/hcs2.70021
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Background To evaluate sex‐related differences in the risk factors associated with nonhealing or recurrence of hyperthyroidism (NHRH) in patients with Graves' disease (GD) treated with radioactive iodine. Methods In total, 285 patients were enrolled. Data on radioactive iodine (RAI) dosage, ultrasound indexes of the thyroid, and other clinical factors were collected. Patients were divided into NHRH and non‐NHRH (hypothyroidism or euthyroidism) groups based on treatment outcomes. Univariate and multivariate weighted logistic regression analyses were used to identify factors associated with NHRH. Sex‐specific analyses of these risk factors were also conducted. Results There were no significant differences between the two groups in terms of sex, thyroid shear wave elastography velocity values, or pretreatment serum free thyroxine (FT4) levels. Thyroid volume and age were independently associated with NHRH, with the odds of NHRH gradually decreasing as age increased. In subgroup analyses, both age and thyroid volume were independent risk factors for NHRH in female patients (p < 0.05), while in male patients, only FT4 was independently associated with NHRH (p < 0.05). Conclusions In patients of different sexes, the influence of thyroid volume, age, and FT4 on treatment outcomes exhibits distinct patterns.
ISSN:2771-1757